Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma

Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma

Background: Immune checkpoints play crucial roles in the immune escape of cancer cells. However, the exact prognostic values of expression and methylation of programmed-death 1 (PD-1), programmed-death-ligand 1 (PD-L1) and PD-L2 in low-grade glioma (LGG) have not been well-defined yet. Methods: A to...

Full description

Bibliographic Details
Main Authors:	Jie Mei, Yun Cai, Rui Xu, Xuejing Yang, Weijian Zhou, Huiyu Wang, Chaoying Liu
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-05-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/15330338211011970

Similar Items

A comparability study of natural and deglycosylated PD-L1 levels in lung cancer: evidence from immunohistochemical analysis
by: Jie Mei, et al.
Published: (2021-01-01)

Methylation of PD-1 Promoter Gene as New Prognostic Marker for IDH Mutant Low-Grade Glioma?
by: Christine Marosi
Published: (2018-03-01)

PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
by: Silvia Pesce, et al.
Published: (2019-06-01)

Downregulation of the PD-1/PD-Ls pathway in peripheral cells correlates with asbestosis severity
by: Meihua Qiu, et al.
Published: (2021-05-01)

BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in Mycobacterium tuberculosis Infection
by: Qianqian Liu, et al.
Published: (2019-10-01)

The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis
by: Song Xue, et al.
Published: (2017-06-01)

Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway
by: Thamiris Becker Scheffel, et al.
Published: (2021-02-01)

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
by: Song Xue, et al.
Published: (2017-04-01)

The Prognostic and Therapeutic Value of PD-L1 in Glioma
by: Ruo Qiao Chen, et al.
Published: (2019-01-01)

Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
by: Tian Yun, et al.
Published: (2020-01-01)

Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids
by: Mingbiao LI, et al.
Published: (2016-12-01)

Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients
by: Liu C, et al.
Published: (2020-06-01)

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
by: Jiawen Qian, et al.
Published: (2018-10-01)

PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
by: Lea Kristin Röver, et al.
Published: (2018-02-01)

The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas
by: Shujun Liu, et al.
Published: (2020-01-01)

Function of PD-L1 in antitumor immunity of glioma cells
by: Yongli Lou, et al.
Published: (2017-05-01)

DNA Methylation Biomarkers Predict Objective Responses to PD-1/PD-L1 Inhibition Blockade
by: Gang Xue, et al.
Published: (2019-08-01)

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
by: Takashi Kawahara, et al.
Published: (2018-11-01)

Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
by: Qigen Fang, et al.
Published: (2021-08-01)

PD-1 related transcriptome profile and clinical outcome in diffuse gliomas
by: Shuai Liu, et al.
Published: (2018-02-01)

Significance of PD-1/PD-1 ligand signaling in Hodgkin lymphoma and anaplastic large cell lymphoma
by: Yamamoto, Ryo
Published: (2010)

Prognostic significance of clinical parameters in patients with cerebral low-grade glioma
by: Joković Miloš, et al.
Published: (2021-01-01)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
by: Luyan Mu, et al.
Published: (2018-03-01)

Low-Temperature Activity and PdO-PdOx Transition in Methane Combustion by a PdO-PdOx/γ-Al2O3 Catalyst
by: Anil C. Banerjee, et al.
Published: (2018-06-01)

Gradient material Pd-PdHx
by: M. V. Goltsova, et al.
Published: (2018-10-01)

Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma
by: Justyna M. Przystal, et al.
Published: (2021-05-01)

Estudos sobre a quimissorção de CO em Pd, Pd-P, Pd-S e Pd-Cu
by: Cunha, Sidney Pinto da
Published: (1981)

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
by: Zi-Lu Huang, et al.
Published: (2019-05-01)

Low-grade Gliomas
by: Whitfield, Peter, et al.
Published: (2011-01-01)

Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma
by: Jie Mei, et al.
Published: (2020-09-01)

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
by: Yanyan Tang, et al.
Published: (2020-04-01)

Investigation of the dHvA in Pd, Pd(Ni) and Pd(Fe) alloys
by: Wise, P.
Published: (1987)

PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
by: Kelly L Barton, et al.
Published: (2013-01-01)

Evaluation of PD-L1 and PD-1 expression in aggressive eyelid sebaceous gland carcinoma and its clinical significance
by: Perumal Jayaraj, et al.
Published: (2019-01-01)

SIGNIFICANCE OF PROGNOSTIC FACTORS IN THE MULTIMODALITY TREATMENT OF SUPRATENTORIAL INFILTRATIVE LOW-GRADE GLIOMAS
by: V. A. Solodkiy, et al.
Published: (2016-07-01)

Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors
by: Di Chen, et al.
Published: (2020-06-01)

Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer
by: Yılmaz Baş, et al.
Published: (2021-02-01)

Preparation and Characterization of Pd and AgPd Nanostructures
by: Zih-Hao Guo, et al.
Published: (2007)

Advances of PD-1/PD-L1 Inhibitors in Tumor Immunotherapy
by: Yong-jun LIU, et al.
Published: (2017-06-01)

Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance
by: Priya Veluswamy, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_9f8u3ma0quh0uokqk33at1jkhp